DOI:
10.1055/s-00000059
Pneumologie
LinksClose Window
References
Seersholm N, Wencker M, Banik N. et al.
Does alpha1-antitrypsin augmentation therapy slow the annual decline in FEV1 in patients with severe hereditary alpha1-antitrypsin deficiency? Wissenschaftliche Arbeitsgemeinschaft zur Therapie von Lungenerkrankungen (WATL) alpha1-AT study group.
Eur Respir J 1997;
10: 2260-2263
We do not assume any responsibility for the contents of the web pages of other providers.